Le Lézard
Classified in: Science and technology
Subject: ACC

Elron Announces Board of Directors Decision Regarding Voluntary Sec Deregistration and Discontinuation of Reporting Obligations in the U.S.


TEL AVIV, Israel, August 28, 2017 /PRNewswire/ --

Elron Electronic Industries Ltd. (TASE: ELRN; OTC PINK: ELRNF) today announced that its Board of Directors has resolved to voluntarily deregister the Company's ordinary shares under the U.S. Securities and Exchange Act of 1934, as amended, after which the Company will no longer be subject to reporting obligations to the Securities and Exchange Commission (the "SEC").

The Company's shares will continue to be traded on the Tel-Aviv Stock Exchange, and the Company will continue to file reports in Israel pursuant to the Israeli Securities Law, 1968, and its regulations. In addition, the Company expects that its ordinary shares will continue to trade on OTC Pink (the "Pink Sheets") immediately following the deregistration. It has not arranged for any other U.S. listing or registration on any other exchange or quotation medium within the U.S.

Following such deregistration, the Company will cease filing reports with the SEC. However, the Company intends to publish, in English, on its website, financial information and certain other material information filed with the Tel Aviv Stock Exchange or otherwise provided to its shareholders.

In order to discontinue its reporting obligations in the U.S., the Company satisfied for the first time during the second quarter of 2017, certain conditions for deregistration pursuant to U.S. federal securities laws, including among others that less than 5% of the worldwide average daily trading volume in the Company's shares took place in the U.S. during the last 12 months (ended July 31, 2017).

In deciding to voluntary deregister its ordinary shares, the Board considered the following:

The Company plans to file with the SEC, the required documents to deregister and terminate its reporting obligations under U.S. federal securities laws. Such reporting obligations will be suspended immediately upon filing and will be terminated 90 days thereafter if there are not objections from the SEC. The Company reserves the right to delay or withdraw the filings for any reason prior to effectiveness.

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words "intends," "plans," "expects," "believes," or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with the SEC discretion, and changes in the Company's business environment, which may lead to a scenario that prior to the completion of the deregistration, the Board shall determine not to carry it out.  

SOURCE Elron Electronic Industries Ltd


These press releases may also interest you

at 16:40
FalconStor Software, Inc. , a trusted data protection leader modernizing disaster recovery and backup for the hybrid cloud world, today announced financial results for its first quarter of 2024, which ended on March 31, 2024. "In Q1, we continued...

at 16:40
Rimini Street, Inc. , a global provider of end-to-end enterprise software support, products and services, the leading third-party support provider for Oracle and SAP software, and a Salesforce and AWS partner, today announced that TrustRadius has...

at 16:40
Johnson & Johnson will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12th, at the Loews Miami Beach Hotel, Miami Beach, Florida. Jennifer Taubert, Executive Vice President, Worldwide Chairman,...

at 16:40
Salesforce , the global leader in CRM, today announced that its first quarter fiscal year 2025 results will be released on Wednesday, May 29, 2024, after the close of the market. The company will host a conference call at 2:00 p.m. (PT) / 5:00 p.m....

at 16:37
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that it has set a record date of May 17, 2024 (the "Record Date") for the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary, Inhibrx...

at 16:35
DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and cardio-renal disease, today provided a business update and financial results for the quarter ended March...



News published on and distributed by: